We recognize that cancer therapies yield different outcomes for individual patients.
Our mission is to improve patient outcomes through
innovative macrocycle-mediated targeted delivery systems.
We are committed to developing versatile, multi-modal platforms that
enhance the effectiveness of targeted cancer therapies.

Co-founder, CEO &
Board Director

Co-founder, CTO & Executive Chairman

Executive Vice Chairman
Capital Formation, Corporate Strategy, & Alliance Management
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.